SCHEMBL4431015

SCHEMBL4431015

CCOP(=O)(O)CNS(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
MEN1 O00255 1/20 0.47
PKM P14618 1/20 0.47
KMT2A Q03164 1/20 0.47
MMP1 P03956 2/20 0.45
MMP2 P08253 2/20 0.45
MMP9 P14780 2/20 0.45
MMP8 P22894 2/20 0.45
MMP13 P45452 2/20 0.45
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP14 P50281 1/20 0.44
MEP1B Q16820 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904614 0.81 ALDH1A1 (0.56) ALDH1A1CA1CA2MEN1PKM
SCHEMBL4431011 0.77 ALDH1A1 (0.53) ALDH1A1CA1CA2MEN1PKM
SCHEMBL6290082 0.73 ALDH1A1 (0.68) ALDH1A1CA1CA2MEN1PKM
SCHEMBL894078 0.73 ALDH1A1 (0.44) ALDH1A1KMT2ALMNAPOLBTDP1
Hydrochloric Acid SCHEMBL27906805 0.72 ALDH1A1 (0.66) ALDH1A1CA1CA2MEN1PKM
SCHEMBL6506619 0.72 ALDH1A1 (0.64) ALDH1A1CA1CA2MEN1PKM
SCHEMBL4551956 0.71 CYP2C9 (0.54) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL4427284 0.71 GAA (0.50) ALDH1A1CA1CA2MEN1KMT2A
SCHEMBL14046920 0.71 ALDH1A1 (0.70) ALDH1A1CA1CA2MEN1PKM
SCHEMBL4431904 0.71 FFAR4 (0.53) ALDH1A1MEN1KMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514556-B2 Inhibitors of β-lactamase METHYLGENE INC. (CA) 2009-04-07 US disclosed
US-20070293675-A1 Novel Inhibitors Of Beta-Lactamase METHYLGENE, INC. (CA) 2007-12-20 US disclosed
US-7259172-B2 phenyl or thien-2-yl substituted amide methyl phosphonate or phosphonyl halide derivatives; do not require a beta -lactam pharmacophore; bactericides; antibiotic resistance METHYLGENE INC. (CA) 2007-08-21 US disclosed
US-20060105999-A1 Novel inhibitors of beta-lactamase METHYLGENE, INC. (CA) 2006-05-18 US disclosed
US-7030103-B2 Sulfonamidomethyl phosphonate inhibitors of β-lactamase METHYLGENE, INC. (CA) 2006-04-18 US disclosed
EP-1194436-B1 SULFONAMIDOMETHYL PHOSPHONATE INHIBITORS OF BETA-LACTAMASE METHYLGENE INC (CA) 2005-11-30 EP disclosed
US-6921756-B2 Inhibitors of β-lactamase METHYLGENE, INC. (CA) 2005-07-26 US disclosed
US-6884791-B2 Inhibitors of β-lactamase METHYLGENE, INC. (CA) 2005-04-26 US disclosed
US-20050043276-A1 Novel inhibitors of beta-lactamase METHYLGENE, INC. (CA) 2005-02-24 US disclosed
WO-2004048393-A2 NOVEL INHIBITORS OF β-LACTAMASE METHYLGENE, INC. (CA) 2004-06-10 WO disclosed
US-20040082546-A1 Novel Inhibitors of beta-lactamase METHYLGENE, INC. 2004-04-29 US disclosed
US-20040059115-A1 Novel sulfonamidomethyl phosphonate inhibitors of beta-lactamase 92229129 QUEBEC INC. (CA) 2004-03-25 US disclosed
US-20040029836-A1 Novel inhibitors of beta-lactamase 92229129 QUEBEC INC. (CA) 2004-02-12 US disclosed
US-6472406-B1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase METHYLGENE, INC. (CA) 2002-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043276-A1 Novel inhibitors of beta-lactamase MGAM, LSS, CYP51A1 ALDH1A1 1276/4885CA1 4384/4885CA2 2716/4885
US-20040029836-A1 Novel inhibitors of beta-lactamase LSS, MGAM, COASY ALDH1A1 1038/4885CA1 4178/4885CA2 2629/4885
US-20060105999-A1 Novel inhibitors of beta-lactamase LSS, MGAM, LCT ALDH1A1 1276/4885CA1 4321/4885CA2 2457/4885
US-20040059115-A1 Novel sulfonamidomethyl phosphonate inhibitors of beta-lactamase PGLS, MGAM, STS ALDH1A1 2218/4885CA1 4176/4885CA2 2859/4885
US-20070293675-A1 Novel Inhibitors Of Beta-Lactamase MGAM, LSS, CYP51A1 ALDH1A1 1276/4885CA1 4384/4885CA2 2716/4885
US-20040082546-A1 Novel Inhibitors of beta-lactamase LSS, MGAM, COASY ALDH1A1 1007/4885CA1 4194/4885CA2 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.